MIS spinal surgery player Kyphon expected to continue on bullrun in wake of good results
This article was originally published in Clinica
Executive Summary
Just over a fortnight after it won a patent tussle against orthopaedics rival Disc-O-Tech, Kyphon has once again regaled its shareholders with good news.